Menu
Recruiting NCT07648953

Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors

No phase Interventional HPV Vaccination

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Microvideos: HPV Vaccination Education.
Who it may be relevant to
Registry conditions: HPV Vaccination. Basic parameters: 18 years — 26 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

This exploratory mixed-methods study aims to examine receipt of treatment and decision-making among rural cancer patients in Utah. Guided by Conceptual Model of Healthcare Access, the study will integrate, survey and cancer registry data with patient interviews to better understand how travel burden, socioeconomic conditions, health literacy, and other contextual factors shape treatment location and access to care . While the setting of this research is specific to Utah, a state with vast rural regions and only one National Cancer Institute (NCI)-designated cancer center, the findings may inform policy and practice improvements in other states with similar geographic and healthcare infrastructure. Thus, the study has potential relevance for advancing rural cancer equity nationwide. Understanding how rural cancer patients make treatment decisions is essential to addressing persistent disparities in cancer care access and outcomes. While geographic barriers and structural inequities are well-documented, less is known about the individual and contextual factors that shape patients' choices about where and how to receive treatment. This mixed-methods study will examine receipt of treatment, decision-making, and patient experience among rural cancer patients in Utah, with attention to travel burden, referral pathways, health literacy, and perceived barriers to care.

Interventions

  • Behavioral Microvideos: HPV Vaccination Education
    To educate survivors of childhood cancers about a key cancer prevention strategy, HPV vaccination. The core microvideos will focus on the 5 Ws of HPV vaccination: Who should get vaccinated, What HPV vaccination protects against, When to get vaccinated, Where to access the vaccine, Why it matters-designed particularly for cancer survivors.

Primary outcome measures

  • Feasibility of Microvideo education [Time frame: up to 4 weeks]
Secondary outcome measures (3)
  • Acceptability of Microvideo Education [Time frame: up to 4 weeks]
  • Satisfaction Acceptability of Microvideo Education [Time frame: up to 4 weeks]
  • HPV Vaccine Intention [Time frame: up to 4 weeks]

Eligibility criteria

Inclusion criteria

  • Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.
  • Currently use Facebook or willing to create a Facebook account to use for the duration of the study.
  • At the time of enrollment, have not completed all recommended doses of the HPV vaccine.

Exclusion criteria

  • Unable to speak and understand English.
  • Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.
  • Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Prevention

Study locations

United States · 1 center
  • University of Utah — Salt Lake City

Identifiers

NCT: NCT07648953 · 198894

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗